γ-Amino Butyric Acid Type A Receptor Mutations at β2N265 Alter Etomidate Efficacy While Preserving Basal and Agonist-dependent Activity
Open Access
- 1 October 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 111 (4), 774-784
- https://doi.org/10.1097/aln.0b013e3181b55fae
Abstract
Background Etomidate acts at gamma-Aminobutyric acid type A (GABAA) receptors containing beta2 or beta3, but not beta1 subunits. Mutations at beta residue 265 (Ser in beta1; Asn in beta2 or beta3) profoundly affect etomidate sensitivity. Whether these mutations alter etomidate binding remains uncertain. Methods Heterologously expressed alpha1beta2gamma2L GABAA receptors and receptors with beta2(N265S) or beta2(N265M) mutations were studied electrophysiologically in both Xenopus oocytes and HEK293 cells. Experiments quantified the impact of beta2N265 mutations or substituting beta1 for beta2 on basal channel activation, GABA EC50, maximal GABA efficacy, etomidate-induced leftward shift in GABA responses, etomidate direct activation, and rapid macrocurrent kinetics. Results were analyzed in the context of an established allosteric co-agonist mechanism. Results Mutations produced only small changes in basal channel activity, GABA EC50, maximal GABA efficacy, and macrocurrent kinetics. Relative to wild-type, beta2(N265S) reduced etomidate enhancement of apparent GABA affinity six-fold, and it reduced etomidate direct activation efficacy 14-fold. beta2(N265M) totally eliminated both etomidate modulation of GABA responses and direct channel activation. Mechanism-based analysis showed that the function of both mutants remains consistent with the allosteric co-agonist model and that beta2(N265S) reduced etomidate allosteric efficacy five-fold, whereas etomidate-binding affinity dropped threefold. Experiments swapping beta2 subunits for beta1 indicated that etomidate efficacy is reduced 34-fold, whereas binding affinity drops less than two-fold. Conclusions Mutations at beta2N265 profoundly alter etomidate sensitivity with only small changes in basal and GABA-dependent channel activity. Mutations at the beta2N265 residue or replacement of beta2 with beta1 influence etomidate efficacy much more than binding to inactive receptors.Keywords
This publication has 41 references indexed in Scilit:
- GABA-Induced Intersubunit Conformational Movement in the GABAAReceptor α1M1-β2M3 Transmembrane Subunit Interface: Experimental Basis for Homology Modeling of an Intravenous Anesthetic Binding SiteJournal of Neuroscience, 2009
- General anesthetic actionsin vivostrongly attenuated by a point mutation in the GABAAreceptor β3 subunitThe FASEB Journal, 2002
- Forced Subunit Assembly in α1β2γ2 GABAAReceptors: INSIGHT INTO THE ABSOLUTE ARRANGEMENTJournal of Biological Chemistry, 2002
- Coupled and Uncoupled Gating and Desensitization Effects by Pore Domain Mutations in GABAAReceptorsJournal of Neuroscience, 2002
- The relative amount of cRNA coding for γ2 subunits affects stimulation by benzodiazepines in GABAA receptors expressed in Xenopus oocytesNeuropharmacology, 2002
- Two Different Mechanisms of Disinhibition Produced by GABAAReceptor Mutations Linked to Epilepsy in HumansJournal of Neuroscience, 2002
- Volatile anesthetic actions on the GABAA receptors: contrasting effects of α1(S270) and β2(N265) point mutationsNeuropharmacology, 2002
- Molecular determinants for the action of general anesthetics at recombinant α2β3γ2γ‐aminobutyric acidA receptorsJournal of Neurochemistry, 2001
- Identification of an Amino Acid Defining the Distinct Properties of Murine β1 and β3 Subunit-Containing GABAA ReceptorsJournal of Neurochemistry, 2001
- Allosteric mechanisms in normal and pathological nicotinic acetylcholine receptorsCurrent Opinion in Neurobiology, 2001